150 related articles for article (PubMed ID: 36986098)
1. Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA).
Moussa H; Robitaille K; Pelletier JF; Tourigny R; Fradet Y; Lacombe L; Toren P; Lodde M; Tiguert R; Dujardin T; Caumartin Y; Duchesne T; Julien P; Savard J; Diorio C; Fradet V
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986098
[TBL] [Abstract][Full Text] [Related]
2. Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial.
Guertin MH; Robitaille K; Pelletier JF; Duchesne T; Julien P; Savard J; Bairati I; Fradet V
BMC Cancer; 2018 Jan; 18(1):64. PubMed ID: 29321047
[TBL] [Abstract][Full Text] [Related]
3. Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.
Aronson WJ; Kobayashi N; Barnard RJ; Henning S; Huang M; Jardack PM; Liu B; Gray A; Wan J; Konijeti R; Freedland SJ; Castor B; Heber D; Elashoff D; Said J; Cohen P; Galet C
Cancer Prev Res (Phila); 2011 Dec; 4(12):2062-71. PubMed ID: 22027686
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
5. Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy.
Fradet S; Pelletier JF; Singbo N; Lacombe L; Toren P; Lodde M; Dujardin T; Tiguert R; Fradet Y; Robitaille K; Fradet V
Clin Nutr ESPEN; 2022 Feb; 47():221-226. PubMed ID: 35063205
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
7. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
9. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
10. Polyunsaturated fatty acid supplementation for schizophrenia.
Joy CB; Mumby-Croft R; Joy LA
Cochrane Database Syst Rev; 2003; (2):CD001257. PubMed ID: 12804400
[TBL] [Abstract][Full Text] [Related]
11. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
12. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
[TBL] [Abstract][Full Text] [Related]
13. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease.
Deinema LA; Vingrys AJ; Wong CY; Jackson DC; Chinnery HR; Downie LE
Ophthalmology; 2017 Jan; 124(1):43-52. PubMed ID: 27817918
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
[TBL] [Abstract][Full Text] [Related]
15. Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trial.
Savard J; Moussa H; Pelletier JF; Julien P; Lacombe L; Tiguert R; Caumartin Y; Dujardin T; Toren P; Pouliot F; Lodde M; Fradet Y; Robitaille K; Fradet V
Cancer Med; 2023 Oct; 12(19):20163-20176. PubMed ID: 37787025
[TBL] [Abstract][Full Text] [Related]
16. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy.
Kelavkar UP; Hutzley J; Dhir R; Kim P; Allen KG; McHugh K
Neoplasia; 2006 Feb; 8(2):112-24. PubMed ID: 16611404
[TBL] [Abstract][Full Text] [Related]
17. The effect of fish oil supplementation on serum phospholipid fatty acids profile during pregnancy: A double blind randomized controlled trial.
Farshbaf-Khalili A; Mohamad-Alizadeh S; Darabi M; Hematzadeh S; Mehdizadeh A; Shaaker M; Ostadrahimi A
Women Health; 2017 Feb; 57(2):137-153. PubMed ID: 27011294
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial to determine the efficacy of manufacturers' recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction.
Laidlaw M; Cockerline CA; Rowe WJ
Lipids Health Dis; 2014 Jun; 13():99. PubMed ID: 24952576
[TBL] [Abstract][Full Text] [Related]
19. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation.
Furuhjelm C; Warstedt K; Fagerås M; Fälth-Magnusson K; Larsson J; Fredriksson M; Duchén K
Pediatr Allergy Immunol; 2011 Aug; 22(5):505-14. PubMed ID: 21332799
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
